TrialCannabis and cannabinoid research2021

A Phase 2 Randomized Controlled Trial of the Efficacy and Safety of Cannabidivarin as Add-on Therapy in Participants with Inadequately Controlled Focal Seizures.

Martin J Brodie et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.